Title: Whatever happened to the lifestyle drugs
1- Whateverhappened to the lifestyle drugs?
William Horsley Gillian Masters Regional Drug
Therapeutics Centre, Newcastleand Dr Wasim
Baqir North Tyneside General Hospital
2September 1998
3(No Transcript)
4(No Transcript)
5(No Transcript)
6(No Transcript)
7Viagra to flood NHSMirror 21/9/98Viagra will
cost the NHS 50m a yearThe Times
11/9/98Health Chiefs Ban Too Costly
ViagraDaily Mirror 13/9/98 We Wont Charge
NHS Stiff Price For ViagraThe Sun 11/9/98
8Viagra decision reveals half-baked rationing
in NHSThe Times 18/9/98
Premature Elimination
Viagras First FlopThe Mirror 15/9/98
9Obesity Pill May Add to NHS Budget
StrainGuardian 22/9/98Anti-Obesity Pills That
Could Cost NHS 750m a YearDaily Mail
21/9/98Fat-Less Pills Could Gobble Up NHS
CashThe Sun 21/9/98Obesity Treatment Could
Cost 500mThe Times 21/9/98
10Viagra is licensed in Europe but rationed in
BritainBMJ 19/9/98Flushing away the fat BMJ
26/9/98Viagras ups and downsThe Lancet
19/9/98NHS Moves To Restrict Viagra
PrescribingPJ 19/9/98
11Method
- Download data for NE SHA(no boundary changes)
- Convert to daily dose equivalents (bupropion,
orlistat and sibutramine) or actual number of
doses (PDE5Is) - Plot monthly incidence and cumulative charts for
doses and cost
12(No Transcript)
13Bupropion
14Orlistat sibutramine
15Phosphodiesterase inhibitors
16All lifestyle drugs (excl. rimonabant
varenicline)
17What is the burden?
- Nearly 25 million over five years for a SHA with
a population of 2.6 million - Five years ago these drugs accounted for monthly drug expenditure
- Now they account for nearly 1.5
- Growth in prescribing and cost has accelerated in
recent years
18but ..
- Containment has been achieved through active
management and legislative restriction - Prescribing rates and cost growth are
accelerating - Lifestyle drugs may require more intensive and
pro-active management to prevent them realising
the predictions that were made when they were
launched
19(No Transcript)